892 filings
Page 5 of 45
8-K
CPRX
Catalyst Pharmaceuticals Inc
27 Oct 23
Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals
4:30pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
20 Oct 23
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
4:31pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
13 Oct 23
The sNDA Seeks to Increase the Indicated Maximum Daily Dose for FIRDAPSE to 100mg for the Treatment of Lambert-Eaton Myasthenic Syndrome
8:15am
8-K
CPRX
Catalyst Pharmaceuticals Inc
25 Sep 23
Regulation FD Disclosure
5:46pm
S-3ASR
CPRX
Catalyst Pharmaceuticals Inc
8 Sep 23
Automatic shelf registration
4:31pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
25 Aug 23
Departure of Directors or Certain Officers
4:31pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
9 Aug 23
Catalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update
4:34pm
10-Q
2023 Q2
CPRX
Catalyst Pharmaceuticals Inc
Quarterly report
9 Aug 23
4:07pm
4
CPRX
Catalyst Pharmaceuticals Inc
4 Aug 23
CATALYST PHARMACEUTICALS / DONALD A DENKHAUS ownership change
5:00pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
28 Jul 23
Patrick J. McEnany Announces Intention to Retire as CEO of Catalyst Pharmaceuticals by Year-End
4:30pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
21 Jul 23
Catalyst Pharmaceuticals Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
4:30pm
ARS
2022 FY
CPRX
Catalyst Pharmaceuticals Inc
17 Jul 23
Annual report to shareholders
4:30pm
DEF 14A
CPRX
Catalyst Pharmaceuticals Inc
Definitive proxy
12 Jul 23
12:00am
4
Carmen Jeffrey Del
29 Jun 23
CATALYST PHARMACEUTICALS / Carmen Jeffrey Del ownership change
5:00pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
23 Jun 23
Catalyst Pharmaceuticals to License North American Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
4:31pm
3
Tamar Thompson
5 Jun 23
CATALYST PHARMACEUTICALS / Tamar Thompson ownership change
5:00pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
1 Jun 23
Catalyst Pharmaceuticals Reports Positive Momentum in Reaffirms Full Year 2023 Total Revenue Guidance of Between
4:30pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
30 May 23
Catalyst Pharmaceuticals Appoints Tamar Thompson to its Board of Directors
4:32pm
4
Patrick J Mcenany
17 May 23
CATALYST PHARMACEUTICALS / PATRICK J MCENANY ownership change
5:04pm
4
Richard J Daly
16 May 23
CATALYST PHARMACEUTICALS / Richard J Daly ownership change
5:01pm